AMANDA ROWSEY: Open Payments
NPI 1073104626 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,447 in 130 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $2,073 · 2025 $2,447
Food & beverage: $2,447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $663 |
| Ardelyx, Inc. | 25 | $362 |
| Janssen Biotech, Inc. | 11 | $261 |
| Regeneron Healthcare Solutions, Inc. | 9 | $198 |
| Novo Nordisk Inc | 8 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Madrigal Pharmaceuticals | 6 | $98 |
| GENZYME CORPORATION | 4 | $95 |
| Celltrion USA Inc. | 4 | $85 |
Products named: IBSRELA, RINVOQ, DUPIXENT, TREMFYA, Wegovy, CREON, XIFAXAN, ENTYVIO.
Industry payments across KY — which companies pay providers there.
